The idea was created when testing materials were in short supply at the beginning of the pandemic.
When Covid-19 hit Oklahoma, the state had only minimal testing options available. OMRF and OU joined forces to change that.
The drug treats fast-growing, deadly brain cancers with no effective treatment.
As a physician-scientist, Matlock Jeffries will maintain a lab focused on osteoarthritis and will see patients in the foundation’s Rheumatology Center of Excellence.
The Presbyterian Health Foundation has awarded nearly $4.6 million in biomedical research grants to OMRF and OUHSC.
Oklahoma City will be site of the nonprofit alliance’s first major program roll out.